The Nova Civilitas movement leads the protest of some Catholic associations concerned about the possibility of blocking the puberty of children with gender dysphoria, However, their arguments are old and unfounded, here's why.
Catholic associations, col movement New Civilization ​​​​​​in the head, they don't let go of triptorelin, the drug already in use for the treatment of some tumors, but also in the rare cases in which gender dysphoria is certified in pre-adolescent boys, blocking their puberty. According to what they claim, it would instead be an excess due more to issues dictated by an unidentified "gender propaganda", while there would be no scientific confirmation.
It is clear that such ferociously invasive and intimately harmful interventions affect children, without even the necessary awareness of the psycho-physical consequences that such treatments could have on the subjects treated, indeed with adverse scientific and ethical evidence, they are to be firmly stigmatized and blamed as actions, to say little, from irresponsible.

New Civilization, in the person of its President, the lawyer. Gianfranco Amato who for years has denounced the deleterious effects of ideological propaganda and the high risk of transposing its dangerous principles into legal norms and medical-scientific protocols, is close to all those women and men who want to work in institutions to ensure that no child on Italian territory can be treated with triptorelin for these purposes.

Gender dysphoria involves an individual's rejection of their sexual gender, it feels exactly as if you were a prisoner of a foreign body, which, when puberty arrives, causes significant psychological trauma, not to mention the misunderstanding that the young person might find in the family and school environment. Which is why once this condition has been ascertained, blocking puberty can be of great help, allowing those who suffer from it to experience the possible gender transition in a peaceful manner.

The Nova Civilitas press release

The fact-finding investigation in the Senate

The controversy started again when AIFA, last February, had included the drug on the list of those payable at the expense of National Health Service. Thus the president of the Senate Health Commission Pierpaolo Sileri allowed a "finding investigation", That will have to evaluate the arguments of the group of Catholic associations against triptorelin, considered the product of a "gender theory" which would allow children and adolescents to "choose" what gender they are.

The legend of the "gender" drug

We therefore find the main false myth that revolves around the protests: the one according to which the goals achieved in the field of research on sexual gender are in reality a mere ideological construct. Not to mention that, in all countries where the treatment has already been adopted, it is well known that it cannot change a person's sex in any way: that is a question that will concern the individual in adulthood, to the fulfillment of 18 years. Administration takes place over a limited period of time, a maximum of two years, in which all competent specialists will be able to further ascertain whether a situation of gender dysphoria is truly present.

Fact checking essenziale

We respond briefly to the statements that have returned to circulation in various media following the protest and the expected discussion at the Senate Health Committee, for further information you can read our previous fact checking:

 
«There is currently no scientific research considered “definitive”».
It is not clear here what is meant by "definitive". Scientific research shows to date that blocking puberty in confirmed cases of gender dysphoria helps pre-adolescents to live their sexuality peacefully while avoiding trauma.
«There are scientific societies that would like to completely exclude the use of triptorelin due to the very serious medical and psychological contraindications».
All the competent associations are not against triptorelin. In reality, this treatment serves to prevent psychological problems above all.
«There are those who are willing to evaluate its use on a case-by-case basis, in very rare cases, under careful psychological control".
This is actually the practice: treatment is prescribed only in rare cases with expert supervision, including psychologists.
«A recent investigation by Times talks about five doctors who dealt with gender dysphoria who asked to resign".
Il Times in the article entitled «Calls to end transgender ‘experiment on children’» does not cite any scientific research or systematic reviews, such as to contradict current knowledge on the safety of the use of triptorelin in children with proven gender dysphoria. The resigning doctors allude to alleged irregularities with respect to the scheduled checks, while the clinic defends itself by confirming that these are being followed. The function of the measures envisaged is not questioned, but rather the fact that a clinic may have implemented them.
source – https://www.open.online/fact-checking/2019/04/10/news/la_protesta_delle_associazioni_cattoliche_contro_il_farmaco_gender_arriva_in_senato-189464/